FINWIRES · TerminalLIVE
FINWIRES

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

By

Moderna (MRNA) has an average rating of hold and mean price target of $56.58, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Price: $156.15, Change: $+93.19, Percent Change: +148.01%

Related Articles

Research

TD Cowen Upgrades BRP to Buy From Hold, CA$106 Price Target

TD Cowen Upgrades BRP to Buy From Hold, CA$106 Price Target

$DOO
Research

Stifel Downgrades Weave Communications to Hold From Buy, Adjusts Price Target to $7.40 From $8

Weave Communications (WEAV) has an average rating of overweight and mean price target of $7.93, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $7.29, Change: $+1.76, Percent Change: +31.74%

$WEAV
Research

Piper Sandler Downgrades Weave Communications to Neutral From Overweight, Adjusts PT to $7.40 From $8

Weave Communications (WEAV) has an average rating of overweight and mean price target of $7.93, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $7.29, Change: $+1.76, Percent Change: +31.74%

$WEAV